Moreover, the albumin administration in the early phase could also reduce disease severity in ARDS patients (Uhlig et al., 2014) and improve vascular endothelial function in septic shock patients (Ospina-Tascon et al., 2010; Hariri et al., 2018). The gene discussed is ALB; the disease is septic shock.